BIOREGENX, INC. PE Ratio
The price-to-earnings (P/E) ratio tells you how many dollars investors pay for each dollar of a company's annual profit. It is market capitalization divided by net income over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher P/E means investors are paying more for each dollar of current earnings, often because they expect profits to grow; a negative P/E means the company lost money over those four quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.
- BIOREGENX, INC. pe ratio for the quarter ending 2026-03-31 was -8.64, a change of -7.68 year-over-year.
- BIOREGENX, INC. pe ratio for the quarter ending 2025-12-31 was -8.1, a change of -7.72 year-over-year.
- BIOREGENX, INC. pe ratio for the quarter ending 2025-09-30 was -0.79, a change of 2.13 year-over-year.
- BIOREGENX, INC. pe ratio for the quarter ending 2025-06-30 was -0.6, a change of 2.26 year-over-year.
- BIOREGENX, INC. pe ratio for fiscal 2026 was -8.64.
- BIOREGENX, INC. pe ratio for fiscal 2025 was -8.1, a change of -7.72 from fiscal 2024.
- BIOREGENX, INC. pe ratio for fiscal 2024 was -0.37, a change of 4.66 from fiscal 2023.
- BIOREGENX, INC. pe ratio for fiscal 2023 was -5.03, a change of 184.42 from fiscal 2022.
- Available history
- 2022-12-31 to 2026-03-31
- Data captured